PETS PETMED EXPRESS INC revenue, earnings and financials

For the quarter ended June 30, 2026, PETMED EXPRESS INC reported revenue of $41.0M (down 19.9% from a year earlier), net income of −$6.15M and diluted EPS of −$0.28; over the last four quarters revenue was $169M and net income −$29.3M; for the fiscal year ended March 2026 revenue was $179M, down 21.1% on the year before.

PETS annual revenue and earnings

• Fiscal year ended Mar 2026: revenue $179M, gross profit $50.2M, operating income −$58.7M, net income −$57.3M (margin -32.0%), EPS −$2.74
• Fiscal year ended Mar 2025: revenue $227M, gross profit $69.1M, operating income −$1.53M, net income −$6.27M (margin -2.8%), EPS −$0.30
• Fiscal year ended Mar 2024: revenue $274M, gross profit $84.8M, operating income −$8.16M, net income −$7.46M (margin -2.7%), EPS −$0.37
• Fiscal year ended Mar 2023: revenue $248M, gross profit $76.5M, operating income $6.05M, net income $5.14M (margin 2.1%), EPS $0.25
• Fiscal year ended Mar 2022: revenue $272M, gross profit $76.9M, operating income $24.3M, net income $18.7M (margin 6.9%), EPS $0.92

PETS quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $41.0M (down 19.9% year over year), net income −$6.15M, EPS −$0.28
• Quarter ended Mar 31, 2026 (from the annual report): revenue $42.8M (down 15.6% year over year), net income −$4.07M, EPS −$0.18
• Quarter ended Dec 31, 2025: revenue $40.7M (down 21.7% year over year), net income −$10.6M, EPS −$0.50
• Quarter ended Sep 30, 2025: revenue $44.4M (down 23.6% year over year), net income −$8.52M, EPS −$0.41
• Quarter ended Jun 30, 2025: revenue $51.2M (down 22.7% year over year), net income −$34.2M, EPS −$1.65
• Quarter ended Mar 31, 2025 (from the annual report): revenue $50.8M (down 22.0% year over year), net income −$11.6M, EPS −$0.56
• Quarter ended Dec 31, 2024: revenue $52.0M (down 18.4% year over year), net income −$707K, EPS −$0.03
• Quarter ended Sep 30, 2024: revenue $58.0M (down 16.4% year over year), net income $2.33M, EPS $0.11
• Quarter ended Jun 30, 2024: revenue $66.2M (down 12.8% year over year), net income $3.75M, EPS $0.18
• Quarter ended Mar 31, 2024 (from the annual report): revenue $65.1M (up 8.8% year over year), net income −$5.01M, EPS −$0.24
• Quarter ended Dec 31, 2023: revenue $63.7M (up 11.2% year over year), net income −$2.03M, EPS −$0.10
• Quarter ended Sep 30, 2023: revenue $69.5M (up 10.0% year over year), net income $715K, EPS $0.03
• Quarter ended Jun 30, 2023: revenue $75.9M (up 12.6% year over year), net income −$1.14M, EPS −$0.06
• Quarter ended Mar 31, 2023 (from the annual report): revenue $59.8M (down 9.2% year over year), net income −$216K, EPS −$0.01
• Quarter ended Dec 31, 2022: revenue $57.2M (down 5.5% year over year), net income −$212K, EPS −$0.01
• Quarter ended Sep 30, 2022: revenue $63.2M (down 5.9% year over year), net income $2.88M, EPS $0.14
• Quarter ended Jun 30, 2022: revenue $67.4M (down 14.4% year over year), net income $2.69M, EPS $0.13
• Quarter ended Mar 31, 2022: revenue $65.8M (down 8.1% year over year), net income $5.54M, EPS $0.30
• Quarter ended Dec 31, 2021: revenue $60.6M, net income $3.82M, EPS $0.21
• Quarter ended Sep 30, 2021: revenue $67.1M, net income $5.77M, EPS $0.31

PETS cash flow, buybacks and dividends

• Fiscal year ended Mar 2026: operating cash flow −$28.4M, share buybacks n/a, dividends $0.00 per share
• Fiscal year ended Mar 2025: operating cash flow $4.72M, share buybacks n/a, dividends $0.00 per share
• Fiscal year ended Mar 2024: operating cash flow $4.32M, share buybacks n/a, dividends $0.60 per share
• Fiscal year ended Mar 2023: operating cash flow $27.8M, share buybacks n/a, dividends $1.20 per share
• Fiscal year ended Mar 2022: operating cash flow $18.5M, share buybacks $0, dividends $1.20 per share

PETS balance sheet

• Jun 30, 2026: cash $13.1M, total assets $63.8M, total liabilities $40.8M, shareholders' equity $23.0M
• Mar 31, 2026: cash $21.4M, total assets $81.2M, total liabilities $52.3M, shareholders' equity $28.9M
• Dec 31, 2025: cash $26.9M, total assets $88.0M, total liabilities $55.2M, shareholders' equity $32.8M
• Sep 30, 2025: cash $36.1M, total assets $100M, total liabilities $57.2M, shareholders' equity $43.1M
• Jun 30, 2025: cash $41.1M, total assets $110M, total liabilities $58.3M, shareholders' equity $51.5M
• Mar 31, 2025: cash $54.7M, total assets $149M, total liabilities $63.6M, shareholders' equity $85.1M
• Dec 31, 2024: cash $50.1M, total assets $145M, total liabilities $48.6M, shareholders' equity $96.2M
• Sep 30, 2024: cash $52.0M, total assets $146M, total liabilities $49.6M, shareholders' equity $96.4M

What is PETS's revenue?

PETMED EXPRESS INC reported $169M of revenue over its last four quarters, through June 30, 2026.

Is PETS profitable?

No. PETMED EXPRESS INC lost $29.3M over the last four quarters.

What is PETS's EPS?

Diluted earnings per share over the last four quarters were −$1.37; −$0.28 in the latest quarter.

Does PETS pay a dividend?

PETMED EXPRESS INC paid $0.60 per share in dividends in the fiscal year ended March 2024.

PETS ownership and insider trades · All stocks